MMP8 and psoriasis: A study from Li et al. (57) demonstrated that SA displayed anti-proliferation and anti-inflammatory effects via suppressing the matrix metalloproteinase 8 (MMP8) expression and IL-17 signaling pathway activation, thereby reducing imiquimod-induced psoriasis-like skin lesions.